Dear Editor: A few reports of sertraline-induced akathisia and dystonia are available, but reporting on sertraline-induced Parkinsonism is negligible (1). We report a case of Parkinsonism associated with sertraline use. To our knowledge, this is the first case in the literature to highlight a possible relation between selective serotonin reuptake inhibitors (SSRIs) and lactic acid metabolism.
Case Report
Mrs L, aged 45 years, is a married, middleclass housewife. She was premorbidly well adjusted and had no significant psychiatric or medical history and no significant family history. She presented with a 2-month history of persistent sadness, frequent crying spells, suicidal ideation, agitation, feelings of hopelessness and worthlessness, disturbed biological functioning, and weight loss of 5 kg. Her illness was precipitated by severe financial losses in her husband's business. Moreover, he had taken a large loan to start his business, and his creditors were demanding payment. Their visits to the home caused her to become markedly restless and apparently unresponsive to her surroundings for periods of 30 minutes to 2 hours. She emerged from these spells when cold water was sprinkled on her face. Mrs L was hospitalized in a private nursing home and given tablet alprazolam 0.5 mg daily and intravenous fluid with parental B complex. She was later referred to our hospital, where all medication was discontinued on admission. She was diagnosed with major depression with conversion disorder and was started on sertraline 50 mg daily and clonazepam 1 mg daily. We increased her sertraline to 100 mg daily on the fourth day of admission. The next day, she developed excessive salivation, mask-like facies, bradykinesia, cogwheel rigidity, tremors of both hands, and monotonous speech. We immediately discontinued sertraline, and she was given intramuscular promethazine 50 mg, with partial response. We sought the opinion of a neurologist on the same day, and Mrs L was given a diagnosis of possible sertalineinduced Parkinsonism. According to the Extrapyramidal Symptom Rating Scale (2), her Parkinsonism was moderately severe. We started her on trihexyphenidyl 2 mg daily, increased to 6 mg daily over a period of 7 days. She was maintained on this dosage for 10 days, and her extrapyramidal symptoms (EPS) fully remitted. However, when trihexyphenidyl was tapered to 2 mg daily, the Parkinsonism symptoms reappeared. We therefore increased the dosage of trihexyphenidyl back to 6 mg daily, with successful results. Because her symptoms reappeared, she was investigated thoroughly. Magnetic resonance imaging (MRI) of the head revealed bilateral basal ganglia focal hyperintensities without any specific lesion. She had a normal biochemical profile for blood sugar, urea, serum creatinine, calcium phosphorus, and alkaline phosphatase. Her serum lactic acid at rest, taken on day 12, was 26.0 mg%. Because of her MRI report and raised lactic acid level, we suspected possible mitochondrial cytopathy; hence, a muscle biopsy was performed. All these investigations were carried out during the reappearance of her Parkinsonism symptoms. A histopathological study of the muscle did not reveal significant pathology, including the existence of ragged fibres. A repeat serum lactic acid level, taken at a 2-week interval, was 24 mg%. Although Mrs L's EPS improved, she continued to have the same psychiatric symptoms. We therefore added dothiepin hydrochloride on the fifth week of admission, and gradually increased this medication to 75 mg daily. A third serum lactic acid level test, taken 2 weeks after the last sample, was 16.00 mg%. The trihexyphenidyl was gradually weaned over 2 weeks without recurrence of the Parkinsonism symptoms. Mrs L continued to take dothiepin hydrochloride for the next 4 months. Her subsequent serum lactic acid levels were 13 mg% and 12 mg%.
Most earlier case reports have not attempted to uncover underlying mechanisms for antidepressant-induced EPS. Although her MRI head scan showed no structural abnormalities in the basal ganglia, our patient developed Parkinsonism along with elevated serum lactic acid after the use of sertraline. This could be coincidental, or possibly, use of sertraline unveiled the Parkinsonism. Mrs L's elevated serum lactic acid levels later returned to normal. Lactic acid is the end product of pyruvate metabolism. Under physiological conditions, lactic dehydrogenase converts lactate to pyruvate, which is metabolized through the citric acid cycle. An elevated lactic acid level may imply a disturbance in mitochondrial oxidative metabolism. Mrs L's elevated lactic acid correlated clinically with her Parkinsonism symptoms. The reversible elevated lactic acid level in this case is perhaps attributable to reversible disturbances in the mitochondrial oxidative metabolism. However, Mrs L's muscle biopsy report was normal, which suggests neither mitochondrial encephalopathy nor disturbances in the oxidative metabolism (3). This case report shows that Parkinsonism can occur with sertraline therapy, although it may be a rare side effect. 
Delusion of Oral Parasitosis in a Patient with Major Depressive Disorder
Dear Editor: Delusion of parasitosis is a false belief in which sufferers have a strong conviction that they are infested with small, insect-like organisms. Patients believe that these organisms live and thrive in their skin and, sometimes, in other parts of their bodies. This condition is also named Ekbom's syndrome (1) . The delusion may exist as a core symptom in patients with delusional disorder, somatic type, or it may be one of the symptoms in other psychiatric disorders. We describe a patient with major depressive disorder who suffered from delusion of parasitosis of the oral cavity. To our knowledge, there is only one previous report of oral parasitosis.
Case Report
The patient is a married housewife, aged 31 years, with a Grade 10 education. She lives in Kerman, a city in the south of Iran. The patient's symptoms started 4 months prior to her referral. She was restless and suffered from deep depression. She said that she hated the world, that there was no future for her, and that everything was meaningless. She stated that she was only a moving corpse. Since the beginning of her illness, she had heard voices telling her that she would return to life on the day of resurrection and that, because she would be hungry, she would have to eat lizards, beetles, and crickets. After hearing these voices, she felt these organisms in her mouth. To remove them, she repeatedly chewed and swallowed, also feeling the taste of chewed materials. She thought that she was sinful and being punished by God. She had insomnia and anorexia and lacked energy to do her duties.
A mental state examination revealed that she had gustatory, tactile, and auditory hallucinations associated with somatic delusions, together with the conviction of being orally infested with tormenting organisms. Her cognition was intact, physical and neurologic examinations were normal, and brain magnetic resonance imaging showed no abnormality. The patient was treated with 150 mg imipramine and 8 mg pimozide daily. She became well 2 months later.
Discussion
Our patient suffered from the delusion that she was infested with several living organisms, including lizards. To our knowledge, all previous case reports describe patients who complained of being infested with only a single small organism; a large organism has not been previously reported. Delusion of parasitosis mainly targets the skin, although a report exists of 4 patients with ocular parasitosis associated with self-inflicted trauma (2) . There is only one prior report of delusion of oral parasitosis: Maeda and others reported the case of an old man with a previous left-sided cerebral infarct who suffered from a delusional conviction that something like a thread was coming out from between his teeth. He could feel worms but not see them. This patient improved with pimozide treatment (3).
One interesting aspect of our patient is her auditory hallucination, which is not directly related to her somatic delusion. A second interesting aspect is that, to remove the disturbing organisms, she repeatedly chewed and swallowed them and then experienced a gustatory hallucination of chewed materials. This phenomenon has not been reported before and can only be observed where delusion of oral parasitosis exists.
Many patients with depression have irrational guilt feelings. Our patient had such guilt feelings; in her case, they were rooted in her religious beliefs, which could have had a special role in forming her delusion.
Our patient improved with combined drug therapy that included pimozide. Since its introduction, pimozide has been regarded as the specific treatment for delusion of parasitosis (4).
Pathological Gambling and Cross-Addiction
Dear Editor: I read with enthusiasm the triad of articles dedicated to pathological gambling in the August 2004 issue of the CJP (1-3) , but when finished, I felt somehow disappointed. The persistent avoidance of even mentioning 12-step-based models of addiction as alternatives to understanding pathological gambling in fact greatly limits the 3 papers.
The editorial by Dr Ladouceur attempts to explain problem gambling in terms of a pure cognitive model (1) wherein pathological gambling stems from the sufferer's inability to understand the independent randomness of chance events, confirmed by the fact that most individuals will hold nonscientific and false beliefs if exposed to gambling. The typical example offered is the situation in which, after the tossing of a coin has resulted in several consecutive tails, most people will believe that chances for heads have increased with the next toss. However, this phenomenon does not explain pathological gambling; it just explains how most people think. It is almost like saying that people gamble because they have 2 feet! As Dr Ladouceur admits, two-thirds of adults gamble, and most people find it difficult to understand randomness, preferring to interpret reality within a deterministic framework. Dr Ladouceur suggests that these false beliefs are more strongly held among problem gamblers than among the general population, and for that reason, they cannot stop gambling, even in the face of loss and self-destruction. This line of reasoning equates to using our knowledge of why the general population drinks moderately to explain why people become dependent on alcohol; it is obviously fallacious. If Dr Ladouceur considered instead a cross-addiction model of pathological gambling, he would not find it difficult to observe the similarities between problem gamblers' insistence on gaming, despite financial ruin, and the persistent addictive behaviour of patients dependent on alcohol or opiates, despite the tragic consequences.
Although Dr Shaffer and others highlight the high levels of comorbidity between chemical addictions and pathological gambling (2), they never consider that this comorbidity could be the manifestation of a common pathology. If the authors had included in the comorbidity with problem gambling not only chemical addictions but also such other addictive behaviours as binge eating and sex addiction, they would have found a concordance close to 100%. Looking at addiction, including pathological gambling, as a unitary problem, would also have helped the authors to understand the life trajectories described in their article. The fact that pathological gamblers are not constantly involved in gambling is not surprising, according to a cross-addiction model. All clinicians involved in addiction treatment observe their patients switching among different addictive behaviours during their lifetime. The addiction is lifelong; the way to express it changes. I am confident that, if the authors were to observe patients who seem to recover from their gambling problem longitudinally, they would realize that, in reality, most have just transferred their addiction to other addictive behaviours such as alcohol abuse, substance
